Congress Releases Highly Anticipated Drug Pricing Legislation
On May 23, 2019, the House Ways and Means Committee released draft legislation that would restructure how Medicare Part D…
Browsing: PBM Reform: Policy Activity
Complex Problems, Complex Solutions
On December 15, 2018, Aimed Alliance counsel Stacey L. Worthy joined staff from the Gabrail Cancer Center on The Cancer…
Drug Formulary Exclusion Lists Reduce Patient Access to Treatment
Drug formulary exclusion lists have grown by 160 percent since 2014, hindering patient access to treatment. By Sara Heath January…
Do Formulary Lists Reduce Patient Access to Prescription Drugs?
Laurie Toich, Associate Editor Formulary lists are used by pharmacy benefit managers (PBMs) to control costs and prevent unnecessary drug…
Aimed Alliance Featured in Latest Issue of American Health & Drug Benefits
The latest issue of American Health & Drug Benefits features an article entitled, “Emphasize Shared Decision-Making Between Physicians and Patients…
Aimed Alliance Op-Ed Featured in Real Clear Health Discussing Pharmacy Benefit Managers
Real Clear Health has published an op-ed by Aimed Alliance’s Executive Director Stacey L. Worthy. The op-ed discusses pharmacy benefit…
Aimed Alliance’s Op-Ed Featured in The Hill: “Should Insurers Be Allowed To Drop Vital Medications without Regard for Patients?”
The Hill has published an op-ed by Aimed Alliance’s Executive Director, Stacey L. Worthy. Ms. Worthy argues that insurers and…
Aimed Alliance’s Op-Ed Featured in Morning Consult: “Who is Getting Rich from the Price of Prescription Drugs?”
Morning Consult has published an op-ed by Aimed Alliance’s Executive Director, Stacey L. Worthy. Ms. Worthy argues a significant portion…
Aimed Alliance Paper Cited in Huffington Post Blog Piece Analyzing Restrictive Insurer Policies
Aimed Alliance’s paper, entitled “Institutional Health Care Rationing Ignores Patients, Undermines Progress, and Leads to Deterioration of Care,” was cited…